Related Experiment Videos
Individual treatment for malignant melanoma
1Department of Surgery, University of Louisville School of Medicine, Kentucky 40292.
Journal of Surgical Oncology
|January 1, 1989
Summary
Recent advances reveal predictable biologic behavior in cutaneous malignant melanoma, enabling personalized treatment strategies. This approach optimizes surgical outcomes by considering patient demographics, lesion location, and Breslow thickness.
Area of Science:
- Dermatology and Oncology
- Surgical Pathology
Background:
- Significant advancements in understanding cutaneous malignant melanoma (CMM) have occurred over the past decade.
- The biologic behavior of CMM is now recognized as largely predictable.
Purpose of the Study:
- To highlight the importance of individualized treatment strategies for CMM.
- To emphasize the role of surgeon's judgment in tailoring treatment based on tumor behavior.
Main Methods:
- Utilizing patient demographic data.
- Assessing lesion location.
- Measuring tumor thickness using the Breslow scale.
Main Results:
- Predictable biologic behavior allows for tailored treatment plans.
- Individualized treatment minimizes morbidity while maximizing surgical results.
Conclusions:
- Personalized treatment based on tumor characteristics and patient data is key for optimal CMM management.
- Thoughtful surgical approaches enhance outcomes in primary and secondary treatments for melanoma.